Literature DB >> 18227407

Salt loading increases urinary excretion of linoleic acid diols and triols in healthy human subjects.

Albert W Dreisbach1, Janet C Rice, Shanker Japa, John W Newman, Aster Sigel, Rajan S Gill, Arthur E Hess, Angela C Cemo, Juan P Fonseca, Bruce D Hammock, Juan J L Lertora, L Lee Hamm.   

Abstract

Increased dietary linoleic acid has been associated with reduced blood pressure in clinical and animal studies possibly mediated by prostaglandins. Urinary linoleate and prostaglandin metabolite excretion were investigated in subjects exposed to a salt-loading/salt-depletion regimen. Twelve healthy subjects were recruited from the New Orleans population (before Hurricaine Katrina) and admitted to the Tulane-Louisiana State University-Charity Hospital General Clinical Research Center after a 5-day outpatient lead-in phase on a 160-mmol sodium diet. On inpatient day 1, the subjects were maintained on the 160-mmol sodium diet, and a 24-hour urine specimen was collected. On day 2, the subjects received 2 L of IV normal saline over 4 hours and continued on a 160-mmol Na(+) diet (total: 460 mmol of sodium). Two 12-hour urine collections were obtained. On day 3, the subjects received three 40-mg oral doses of furosemide, two 12-hour urine collections were obtained, and the subjects were given a 10-mmol sodium diet. Urinary oxidized lipids were measured by high-performance liquid chromatography-tandem quadrupole mass spectroscopy. The excretion of the urinary linoleate metabolites, dihydroxyoctadecamonoenoic acids, and trihydroxyoctadecamonoenoic acids increased significantly during intravenous salt loading as compared with day 1 and the salt-depleted periods. The urinary excretion of 6-keto- prostaglandin F1alpha was unaffected by salt loading but was dramatically increased 7- to 10-fold by salt depletion. Prostaglandin E2 excretion was positively correlated with sodium excretion. The salt-stimulated production of linoleic acid diols and triols may inhibit tubular sodium reabsorption, thereby assisting in the excretion of the sodium load.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227407     DOI: 10.1161/HYPERTENSIONAHA.107.100123

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Assessment of soluble epoxide hydrolase activity in vivo: A metabolomic approach.

Authors:  Darko Stefanovski; Pei-An Betty Shih; Bruce D Hammock; Richard M Watanabe; Jang H Youn
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-01-10       Impact factor: 3.072

2.  Endogenous Levels of Five Fatty Acid Metabolites in Exhaled Breath Condensate to Monitor Asthma by High-Performance Liquid Chromatography: Electrospray Tandem Mass Spectrometry.

Authors:  Malin L Nording; Jun Yang; Christine M Hegedus; Abhinav Bhushan; Nicholas J Kenyon; Cristina E Davis; Bruce D Hammock
Journal:  IEEE Sens J       Date:  2010-01-01       Impact factor: 3.301

3.  EP3 (E-Prostanoid 3) Receptor Mediates Impaired Vasodilation in a Mouse Model of Salt-Sensitive Hypertension.

Authors:  Jing Wu; Shi Fang; Ko-Ting Lu; Kelsey Wackman; Michal L Schwartzman; Sergey I Dikalov; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2021-03-01       Impact factor: 9.897

4.  Metabolomics Study of Metabolic Changes in Renal Cells in Response to High-Glucose Exposure Based on Liquid or Gas Chromatography Coupled With Mass Spectrometry.

Authors:  Liang Wang; Yan Du; Bing-Ju Xu; Xu Deng; Qing-Hua Liu; Qiao-Qiao Zhong; Chen-Xiang Wang; Shuai Ji; Meng-Zhe Guo; Dao-Quan Tang
Journal:  Front Pharmacol       Date:  2019-08-20       Impact factor: 5.810

Review 5.  Molecular biochemical aspects of salt (sodium chloride) in inflammation and immune response with reference to hypertension and type 2 diabetes mellitus.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2021-08-01       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.